The Integrated Program in Neuroscience (IPN) invites Dr. Marina Picciotto is give the 2023 Bernice Grafstein Lecture in Neuroscience. Dr. Picciotto is the Charles B. G. Murphy Professor of...
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...